• News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • Subscribe newsletter
  • Search
  • Menu Menu
International Hospital
  • AI
  • Cardiology
  • Oncology
  • Neurology
  • Genetics
  • Orthopaedics
  • Research
  • Surgery
  • Innovation
  • Medical Imaging
  • MedTech
  • Obs-Gyn
  • Paediatrics

Archive for category: Product News

Products News

iCare HOME2

New iCare HOME2 self-tonometer enables easy, accurate eye pressure measurement by glaucoma patients

, 8 April 2021/in Product News /by panglobal

iCare Home2 self-tonometer

Icare Finland, a specilist in providing fast, easy-to-use, and reliable tools for ophthalmic diagnostics, is launching their next generation self-tonometer, the iCare HOME2.

iCare HOME2 provides unsurpassed ease of use and accuracy in monitoring real-world intraocular pressure behaviour outside of the doctor’s office and clinical hours, supporting glaucoma management. Glaucoma is a chronic, progressive disease of the optic nerve. As intraocular pressure (IOP) is the only modifiable risk factor for glaucoma progression, disease management is centred around the reduction of IOP. Therefore, comprehensive and accurate information on peak IOPs and IOP fluctuation patterns is crucial.

Most patients can utilize iCare HOME2 simply by following the advice and guidance in the instruction materials, freeing up health care professionals’ precious time. iCare HOME2’s smart light guide helps the patient in positioning the device correctly and in making the measurements effortlessly and accurately, every time. It is now easier than ever for doctors to provide glaucoma management based on real-world IOP information, from finding the optimal medication and instillation schedule, to assessing the need for and effectiveness of surgery.

iCare PATIENT2 mobile app

With the novel iCare PATIENT2 mobile app, the patients can follow their own IOP trends from an iOS or Android mobile device and send the IOP measurement results easily for healthcare professional’s review in the cloud based iCare CLINIC software. Using iCare HOME2 and PATIENT2, the patient can actively participate in the care process by providing valuable information to the healthcare professional. Patient motivation for medication compliance can improve, and knowledge of the real-time IOP levels provides daily reassurance.

  • For more information, visit: iCare Home2
https://interhospi.com/wp-content/uploads/sites/3/2021/04/iCare_Home2.jpg 533 800 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2021-04-08 14:24:232021-04-08 14:24:23New iCare HOME2 self-tonometer enables easy, accurate eye pressure measurement by glaucoma patients
Horiba receives CE Mark for Microsemi CRP LC-767G

HORIBA Medical receives CE Mark for new generation Microsemi CRP haematology analyser

, 8 April 2021/in Product News /by panglobal

Horiba receives CE Mark for Microsemi CRP LC-767GHORIBA Medical, specialists in automated in vitro diagnostic systems for haematology, haemostasis and clinical chemistry analysis, has obtained the CE Mark certification for its new generation of the Microsemi CRP haematology analyser, the Microsemi CRP LC-767G.

This new generation analyser Microsemi CRP LC-767G is more compact and proposes enhanced software and network connectivity providing higher memory, usability plus a new parameter: Granulocytes-to-Lymphocytes Ratio (GLR). The incredible robustness and ease of use of the Micros range are further improved for this new generation analyser.

Developed by HORIBA Medical in Japan, ‘emi’ means ‘smile’ in Japanese and stands for easy to use, maintenance free and Intelligent. After a highly successful release in Japan, this unique instrument is now available in Europe. This compact, easy to use addition to the Micros range, simultaneously provides a Complete Blood Count (CBC) and C-Reactive Protein (CRP) from just 18 µL of blood – all in just 4 minutes.

Point of Care

The Microsemi CRP LC-767G provides information of great clinical value enabling quicker and more accurate medical decisions at the Point of Care to ultimately reduce hospitalization times and patient costs. Its powerful and accurate CRP analysis allows the screening of patient samples to quantify the presence of inflammation caused by bacterial, viral (e.g. Covid-19), parasitic infections (e.g. malaria) and other treatable inflammatory diseases.

The simultaneous access to Lymphocytes, GLR and CRP provided on this analyser is helpful for Covid-19 patient screening, monitoring and triage. Measurement is possible immediately after blood sample collection from capillary sample, making this analyser the ideal choice for emergency testing situations.

This new Microsemi CRP LC-767G can also be used to assess infection and inflammatory conditions that require progressive observation. Furthermore, its micro-sampling capabilities are ideal for paediatric blood analysis, at the Point of Care requiring just 10µL for CBC and 18 µL for CBC+CRP, and can be used with capillary, as well as venous blood samples.

The Microsemi CRP is easy to use and does not require specialist staff. Comprehensive and efficient on-board software with colour touchscreen and easy to access patient and control results are features of the Microsemi CRP. It is compact, lightweight and quiet.

  • For more information, visit Horiba: Microsemi CRP LC-767G
https://interhospi.com/wp-content/uploads/sites/3/2021/04/Microsemi-CRP-LC-767G_Covid-19_Image_HORIBA-Medical.jpg 720 1280 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2021-04-08 14:12:492021-04-08 14:12:49HORIBA Medical receives CE Mark for new generation Microsemi CRP haematology analyser

ESMO guidelines recommend scalp cooling to prevent chemotherapy-induced alopecia

, 26 February 2021/in Product News /by 3wmedia

The European Society for Medical Oncology (ESMO), the leading professional organisation for medical oncology, has updated the Clinical Practice Guidelines for Dermatological Toxicities Related to Anticancer Agents to include the recommendation of scalp cooling for the prevention of chemotherapyinduced alopecia (CIA) as a Category IIB recommendation.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2021/02/2_ESMO.jpg 643 808 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2021-02-26 12:29:452021-03-01 12:17:16ESMO guidelines recommend scalp cooling to prevent chemotherapy-induced alopecia

Shimadzu releases Advanced i-Series liquid chromatographs

, 26 February 2021/in Product News /by 3wmedia

Shimadzu, one of the world leaders in analytical instrumentation, has release its “Advanced i-Series” liquid chromatographs. The Prominence-i HPLC and Nexera-i UHPLC systems feature pressures of 50 MPa or 70 MPa respectively and can be combined with a variety of detectors. The Advanced i-Series meets user demands for analyzing a large number of samples or […]

Read more
https://interhospi.com/wp-content/uploads/sites/3/2021/02/3B_SHIMADZU.jpg 1276 867 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2021-02-26 12:28:242021-03-01 12:01:39Shimadzu releases Advanced i-Series liquid chromatographs

Philips introduces industry-first vendor-neutral Radiology Operations Command Center

, 26 February 2021/in Product News /by 3wmedia

Philips has unveiled the industry’s first vendorneutral, multimodality, radiology operations command center to add secure, digital, virtual scanner access to existing imaging installs across multiple systems and sites.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2021/02/4C_PHILIPS.jpg 390 1000 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2021-02-26 12:27:532021-03-01 12:05:08Philips introduces industry-first vendor-neutral Radiology Operations Command Center

RheinCell Therapeutics receives Manufacturing Authorization for iPSCs

, 26 February 2021/in Product News /by 3wmedia

RheinCell Therapeutics, a developer and manufacturer of human induced pluripotent stem cells (iPSCs) as starting materials for cell therapies, has received Good Manufacturing Practice (GMP) certification and Manufacturing Authorization. This marks a landmark achievement for RheinCell, which is now among a select few iPSCs manufacturers to have received the critical certification.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2021/02/5_RHEINCELL.jpg 625 808 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2021-02-26 12:26:392021-03-02 08:39:14RheinCell Therapeutics receives Manufacturing Authorization for iPSCs

New version of Bittium Cardiac Navigator analysis software enhances detection of P-wave and atrial fibrillation

, 26 February 2021/in Product News /by 3wmedia

Bittium, a leading specialist for secure communications, connectivity, and medical technology solutions, has released a new version of Bittium Cardiac Navigator Holter ECG Analysis Software. The new Bittium Cardiac Navigator 1.4. Software version brings improvements to the P-wave detection. This will enhance the analysis accuracy of atrial fibrillation. The new version includes also minimum and […]

Read more
https://interhospi.com/wp-content/uploads/sites/3/2021/02/6_BITTIUM.jpg 507 692 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2021-02-26 12:25:222021-03-01 12:08:47New version of Bittium Cardiac Navigator analysis software enhances detection of P-wave and atrial fibrillation

World’s first contact-free robotic-guided laser osteotome is CE certified

, 26 February 2021/in Product News /by 3wmedia

Swiss MedTech start-up Advanced Osteotomy Tools (AOT) has received CE certification for its patented CARLO® system which cuts bones precisely and contact-free with a specialized laser using a robot. CARLO stands for Cold Ablation Robot-guided Laser Osteotome.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2021/02/7_AOT-SWISS.jpg 285 1000 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2021-02-26 12:24:302021-03-02 09:05:04World’s first contact-free robotic-guided laser osteotome is CE certified

Sony launches new 4K HDR medical monitorsystem

, 23 December 2020/in Product News /by 3wmedia

Sony has introduced the LMD-X3200MD 32-inch medical grade LCD monitor with 4K HDR colour imaging. Its sleek design is optimized for hospital operating rooms, surgical centres and clinics.
It is designed to minimize reflected glare in brightly lit ORs, and the panel structure achieves clear, high-contrast images by controlling reflection and minimizing light dispersion in the LCD panel. This allows application of the monitor under various lighting conditions and avoids the need for ongoing adjustment of the monitor in the OR to remove potentially distracting reflections from surgical lights.
The LMD-X3200MD LCD panel and signal processing technology provide a wide colour gamut that complies with the ITU-R Recommendation BT.2020. Offering a wider colour gamut than the BT.709, colour reproduction is significantly improved with realistic visualisation. HDR technology also allows images to be produced with a wider range of brightness level, greater contrast, and rich colours. When receiving HLG (Hybrid Log-Gamma) signals from an HLG-compatible imaging system, users can simply select HLG in monitor gamma setting mode to display HDR images.
“We understand the critical importance in providing a surgeon with the highest quality image that enables greater depiction of finer anatomical structures through a simplified application,” explained Claire Bregeon, Product Marketing Manager for Healthcare at Sony Professional Solutions Europe. ‘‘With 4K resolution combined with HDR, you can see more detail in a dark body cavity and in bright areas with light reflections on membrane surfaces. If the surgeon sees better – they can perform better.”
The LMD-X3200MD also benefits from Sony’s unique A.I.M.E. (Advanced Image Multiple Enhancer) that allows you to adjust the view to enhance structure and colour for more comfortable viewing. This technology has been recently improved with new features including shadow enhancement and noise reduction. Parameters can also be set directly via the button on the front panel.
For more information, visit: www.sony.net
Read more

https://interhospi.com/wp-content/uploads/sites/3/2021/01/4B_PRODUCT_SONY.jpg 607 1000 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-12-23 00:00:002020-12-23 00:00:00Sony launches new 4K HDR medical monitorsystem

Biotronik’s a new injectable cardiac monitor reduces false positive readings

, 23 December 2020/in Product News /by 3wmedia

Biotronik has introduced a new injectable cardiac monitor (ICM). The BIOMONITOR IIIm is equipped with a unique algorithm that significantly reduces false positive atrial fibrillation (AF) detections due to ectopic beats.
Physicians can lose time reviewing these nonactionable episodes. Research shows that 52% of false positive AF episodes occur due to premature ectopic beats, which can be falsely detected as AF.
According to Biotronik, the new device can achieve a 72% reduction in false positives while maintaining 100% of AF-related sensitivity. It removes single ectopic beats out of the AF detection algorithm, enhancing diagnostic accuracy. This will make physicians’ workload more efficient.
These new features are supported by image quality comparable to those recorded on a gold-standard 12-lead ECG.
BIOMONITOR IIIm is also the industry leader in battery longevity with 5.5 years of continuous service, providing long-term post-ablation or cryptogenic stroke monitoring. It is also backed by the Patient App, which allows patients to include vital symptom data, providing physicians with symptom-rhythm correlation which strengthens diagnostic precision.
For more information, visit: www.biotronik.com/en-de/products/arrhythmiamonitoring/ biomonitorIIIm
Read more

https://interhospi.com/wp-content/uploads/sites/3/2021/01/1_PRODUCT_BIOTRONIK.jpg 621 791 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-12-23 00:00:002020-12-23 00:00:00Biotronik’s a new injectable cardiac monitor reduces false positive readings
Page 28 of 83«‹2627282930›»

Latest issue of International Hospital

April 2024

27 June 2025

Scientists launch world first project to create synthetic human genome with £10mn Wellcome funding

27 June 2025

GE HealthCare advances precision imaging with MIM Encore platform

27 June 2025

GE HealthCare advances cardiac PET diagnostics with Flyrcado launch

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The medical devices information portal connecting healthcare professionals to global vendors

Sign in for our newsletter
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Media kit
    • Submit Press Release

Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com

PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only

Sign in for our newsletter

Free subscription